We utilized a combination of Medical Subject Headings (MeSH) terms and keywords such as "Type 2 Diabetes Mellitus", "SGLT2 inhibitors", "DPP-4 inhibitors", "Metformin", "Insulin", and "combination therapy". Here, SLC5A2 is linked to diabetes mellitus.